Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Roberts

Neurological Surgery Fort Lauderdale, FL Doctor of Osteopathy

NPI 1679864581 CMS profile 866188

1601 S Andrews Ave, 3Rd Floor, Fort Lauderdale, FL 33316

Open in the dashboard

General payments

$9,828

420 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Roberts of Fort Lauderdale, FL is reported in the CMS Open Payments database as having received $9,828 across 420 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,231 44
2024 General $1,357 52
2023 General $1,406 90
2022 General $2,488 97
2021 General $2,081 70
2020 General $701 44
2019 General $564 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Roberts
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Christopher Roberts were reported at $1,231. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Christopher Roberts Neurological Surgery median Middle half National median
2019 $564 $582 $138–$3,006 $163
2020 $701 $294 $76–$2,174 $114
2021 $2,081 $387 $105–$2,432 $132
2022 $2,488 $542 $139–$2,989 $149
2023 $1,406 $534 $145–$2,697 $160
2024 $1,357 $574 $155–$3,046 $164
2025 $1,231 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $8,504 382 payments
  2. VB Spine LLC $779 27 payments
  3. Medtronic, Inc. $175 2 payments
  4. Alexion Pharmaceuticals, Inc. $116 1 payment
  5. AstraZeneca Pharmaceuticals LP $102 1 payment
  6. Nevro Corp. $57 2 payments
  7. Portola Pharmaceuticals, Inc. $22 1 payment
  8. Abbott Laboratories $21 1 payment
  9. CSL Behring $20 1 payment
  10. Allergan Inc. $18 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,317 411 payments
  2. Travel and Lodging $376 6 payments
  3. Education $136 3 payments
Products named General payments · program years 2019–2025
  1. N/A $1,171 70 payments
  2. PROLIFT $1,055 53 payments
  3. XIA 3 $799 14 payments
  4. ES2 SPINAL SYSTEM $758 40 payments
  5. SERRATO $636 15 payments
  6. AIRO $560 15 payments
  7. EVEREST SPINAL SYSTEM $374 17 payments
  8. CAPRI CORPECTOMY CAGE SYSTEM $355 23 payments
  9. RAVINE LATERAL ACCESS SYSTEM $348 12 payments
  10. YUKON OCT SPINAL SYSTEM $310 11 payments
  11. Other $3,331 145 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

38

Median for Neurosurgery: 83

Drug cost

$325

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 38 $325

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$79,825

Medicare's payments for the services billed

Medicare patients

142

Average age 74

Services billed

302

62 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 42%
Ischemic heart disease 37%
Depression 34%
Chronic kidney disease 32%
Heart failure 25%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

420 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record